EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ascertaining the Kawasaki Disease–Coronavirus Disease 2019 Linkage in a Japanese Administrative Claims Database

Tomoki Mizuno, Jun Suzuki iD, Shota Takahashi, Haruka Imai, Hideya Itagaki iD, Tomohiro Akaba, Makiko Yoshida, Shiro Endo

Pediatrics International · 2026-01 · 68 (1)

DOI: 10.1111/ped.70420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 28.04.2026. Verfasst von Tomoki Mizuno und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: COVID-19, Mucocutaneous Lymph Node Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid for Scientific Research JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the potential association between Kawasaki Disease (KD) and coronavirus disease 2019 (COVID‐19), real‐world clinical associations remain unclear. We aimed to investigate the association between KD and COVID‐19 using a Japanese claims database.

Methods

Using a Japanese claims database, we identified patients diagnosed with COVID‐19 between January 1, 2020, and December 31, 2022 and conducted the following two analyses: a nested case–control study wherein each KD case was matched 1:4 to controls (without KD), and conditional logistic regression analyses were used to calculate odds ratios (ORs) for COVID‐19 exposure in the previous 1–30, 31–60, and 61–90 days. In the self‐controlled case‐series (SCCS) analysis, the observation comprised the 120 days before and after COVID‐19 diagnosis (Day 0). We calculated the incidence rate ratio (IRR) of three risk periods (Days 1–30, 31–60, 61–90) after Day 0 compared with the control periods.

Results

Nested case–control analysis matched 134 cases with 536 controls. COVID‐19 exposure was identified in 26.1% (35/134) of cases and 7.3% (39/536) of controls during the previous 1–30 days (adjusted OR 7.8, 95% CI 3.2–19), and in 18.7% (25/134) and 8.8% (47/536) during the previous 31–60 days (adjusted OR 3.6, 95% CI 2.0–6.5). SCCS analysis included 124 patients, revealing elevated IRRs on Days 1–30 (95% CI: 11 [6.0–20]), and 31–60 (6.9 [3.6–13]) after COVID‐19 diagnosis.

Conclusion

The present study found that COVID‐19 was associated with the development of KD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Mucocutaneous Lymph Node SyndromeAdolescentChildChild, PreschoolFemaleHumansInfantMaleCase-Control StudiesDatabases, FactualIncidenceJapanSARS-CoV-2

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2multisystem inflammatory syndrome in childrensevere acute respiratory syndrome coronavirus 2

Autor:innen und Institutionen

  • Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan.
  • Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan.
  • Division of Infectious Diseases and Infection Control, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
  • Division of Infectious Diseases and Infection Control, Department of Social and Community Medicine, Graduate School of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
  • Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
  • Division of the Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.

ORCID-Profile: Jun Suzuki, Hideya Itagaki

Förderung

  • Grants-in-Aid for Scientific Research JSPS KAKENHI

Zitieren

APA

Mizuno, T., Suzuki, J., Takahashi, S., Imai, H., Itagaki, H., Akaba, T., Yoshida, M., & Endo, S. (2026). Ascertaining the Kawasaki Disease–Coronavirus Disease 2019 Linkage in a Japanese Administrative Claims Database. Pediatrics International, 68(1). https://doi.org/10.1111/ped.70420

Vancouver

Mizuno T, Suzuki J, Takahashi S, Imai H, Itagaki H, Akaba T, et al. Ascertaining the Kawasaki Disease–Coronavirus Disease 2019 Linkage in a Japanese Administrative Claims Database. Pediatrics International. 2026;68(1). doi:10.1111/ped.70420

BibTeX
@article{Mizuno2026,
  author = {Mizuno, Tomoki and Suzuki, Jun and Takahashi, Shota and Imai, Haruka and Itagaki, Hideya and Akaba, Tomohiro and Yoshida, Makiko and Endo, Shiro},
  title = {Ascertaining the Kawasaki Disease–Coronavirus Disease 2019 Linkage in a Japanese Administrative Claims Database},
  journal = {Pediatrics International},
  year = {2026},
  volume = {68},
  number = {1},
  doi = {10.1111/ped.70420}
}
Kostenlos starten →